Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Maertens

Showing results (221-230 of 361) with videos related to

Pageof 37
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2007
Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)Oliver A Cornely, Johan Maertens, Mark Bresnik, et al.
Bone Marrow Transplantation|September 16, 2022
Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMTArnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Bone Marrow Transplantation|February 6, 2025
Life 2.0: a comprehensive cross-sectional profiling of long-term allogeneic hematopoietic cell transplantation survivors compared to a matched general population cohortHélène Schoemans, Kathy Goris, Steffen Fieuws, et al.
Bone Marrow Transplantation|June 29, 2023
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Enrico Maffini, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categoriesJan J Cornelissen, Dimitri Breems, Wim L J van Putten, et al.
Blood|September 21, 2011
Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patientsLeonardo Potenza, Daniela Vallerini, Patrizia Barozzi, et al.
The Journal of Antimicrobial Chemotherapy|July 29, 2021
Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort studyAnat Stern, Carolyn D Alonso, Carolina Garcia-Vidal, et al.
The Lancet. Infectious Diseases|April 20, 2026
Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry studyAnnalisa Paviglianiti, Per Ljungman, Rafael de la Camara, et al.
Lancet (London, England)|January 18, 2006
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trialStefan Janssens, Christophe Dubois, Jan Bogaert, et al.
Haematologica|July 30, 2013
Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow TransplantationSabine Gerull, Martin Stern, Jane Apperley, et al.
Pageof 37

Showing results (221-230 of 361) with videos related to

Sort By:
Pageof 37
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2007
Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)Oliver A Cornely, Johan Maertens, Mark Bresnik, et al.
Bone Marrow Transplantation|September 16, 2022
Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMTArnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Bone Marrow Transplantation|February 6, 2025
Life 2.0: a comprehensive cross-sectional profiling of long-term allogeneic hematopoietic cell transplantation survivors compared to a matched general population cohortHélène Schoemans, Kathy Goris, Steffen Fieuws, et al.
Bone Marrow Transplantation|June 29, 2023
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Enrico Maffini, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categoriesJan J Cornelissen, Dimitri Breems, Wim L J van Putten, et al.
Blood|September 21, 2011
Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patientsLeonardo Potenza, Daniela Vallerini, Patrizia Barozzi, et al.
The Journal of Antimicrobial Chemotherapy|July 29, 2021
Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort studyAnat Stern, Carolyn D Alonso, Carolina Garcia-Vidal, et al.
The Lancet. Infectious Diseases|April 20, 2026
Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry studyAnnalisa Paviglianiti, Per Ljungman, Rafael de la Camara, et al.
Lancet (London, England)|January 18, 2006
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trialStefan Janssens, Christophe Dubois, Jan Bogaert, et al.
Haematologica|July 30, 2013
Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow TransplantationSabine Gerull, Martin Stern, Jane Apperley, et al.
Pageof 37